Table 1.
Study characteristics.
| Reference (first author) | Period | No. of patients | Type of repair | Type of patch | Open/MIS** | Complications, n (%) | Follow-up | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Patch* | Recurrence | SBO | Chylothorax | ||||||
| Al-Iede | 2000–2013 | 85 | 65 | 20 | PTFE/Dacron | 71/14 | 11 (12.9) | 2y | ||
| Aydin | 2005–2016 | 119 | 28 | 91 | PTFE | 119/12(excl.) | 6 (5.0) | 5ya | ||
| Costerus | 2008–2012 | 109 | 42 | 67 | PTFE | 34/75 | 16 (14.8) | 1y | ||
| Fisher | 1990–2006 | 238 | 128 | 110 | PTFE | 231/7 | 24 (10.1) | |||
| Gander | 2006–2010 | 45 | 17 | 28 | PTFE | 19/26 | 6 (17.1) | 14ma | ||
| Gonzalez | 1997–2008 | 152 | 96 | 56 | Not specified | 137/15 | 10 (6.6) | |||
| Guner | 2004–2008 | 15 | 10 | 5 | Dacron | 0/15 | 3 (20) | 4–14 m | ||
| Hanekamp | 1990–2000 | 89 | 48 | 41 | Not specified | Not specified | 9 (10) | |||
| Jancelewicz (To) | 2000–2011 | 157 | 115 | 42 | PTFE/SIS | 129/28 | 23 (15) | 12 (8) | ||
| Jancelewicz (SF) | 2000–2008 | 99 | 42 | 57 | PTFE/SIS/flap | 94/5 | 30 (30.3) | 13 (13.1) | 4.7ya | |
| Janssen | 2000–2014 | 112 | 77 | 35 | PTFE | Not specified | 8 (7.1) | 22 (19.6) | 7.3yb | |
| Jawaid | 1990–2010 | 118 | 81 | 37 | PTFE/SIS | 118/0 | 2 (1.8) | 2 (1.8) | 8.6ya | |
| Kamata | 1986–2000 | 33 | 18 | 15 | Not specified | Not specified | 4 (12) | 11.4b | ||
| Kamiyama | 1981–2008 | 198 | 109 | 89 | PTFE | Not specified | 11 (5.6) | |||
| Keijzer | 2006–2008 | 46 | 18 | 28 | PTFE | 29/17 | 4 (15) | 1yc | ||
| Laituri | 1994–2009 | 155 | 101 | 54 | PTFE/Dacron/SIS/Alloderm | Not specified | 23 (14.8) | 20 (13) | ||
| Lund | Not specified | 33 | 23 | 10 | PTFE | Not specified | 2 (6.1) | 32mb | ||
| Mills | 2006–2010 | 230 | 159 | 71 | Not specified | Not specified | 11 (4.5) | |||
| Nagata | 2006–2010 | 180 | 112 | 68 | Not specified | 180/0 | 21 (11.6) | 3yc | ||
| Riehle | 1993–1994 | 125 | 79 | 46 | PTFE | Not specified | 2 (1.6) | 6 (4.8) | 27ma | |
| St Peter | 1994–2004 | 81 | 57 | 24 | NA mesh, SIS | Not specified | 10 (12.3) | 8 (9.9) | 7.95ya | |
| Suply | 2000–2016 | 203 | 96 | 107 | PTFE, fibrine | 55/148 | 14 (6.9) | 8 (3.9) | ||
| Tsai | 1999–2010 | 149 | 75 | 74 | PTFE | 136/12 | 7 (8.6) | 5 (3.4) | 2ya | |
| Yokota | 1995–2013 | 74 | 49 | 25 | ‘Artificial patch’ | 74/0 | 8 (10.8) | 13 (17.6) | 50ma | |
| Zavala | 2003–2009 | 65 | 29 | 36 | Not specified | Not specified | 7 (10.8) | |||
*Patch including flap.
**Open: abdominal or thoracotomy, MIS: Thoracoscopic or laparoscopic (Gonzalez, Jancelewicz ((To), 1)).
aMedian, bMean, cMinimum, PTFE = polytetrafluorethylene, m = month(s), NA = non-absorbable, No. = total number, SIS = biological mesh (f.e. Surgisis®) y = year(s).